{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T19:54:25Z","timestamp":1761854065628,"version":"build-2065373602"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T00:00:00Z","timestamp":1682640000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nefrolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.nefroe.2023.04.003","type":"journal-article","created":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T07:39:00Z","timestamp":1683272340000},"page":"90-99","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["\u03b21-Integrin blockade prevents podocyte injury in experimental models of minimal change disease"],"prefix":"10.1016","volume":"44","author":[{"given":"Gabriel","family":"Cara-Fuentes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakesh","family":"Verma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madhusudan","family":"Venkatareddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Piani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sogut Turkmen","family":"Aksoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neha","family":"Vazzalwar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela E.","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mindy","family":"Banks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flor A.","family":"Ordo\u00f1ez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"de Lucas-Collantes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petter","family":"Bjornstad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan D.","family":"Gonz\u00e1lez Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard J.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Puneet","family":"Garg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nefroe.2023.04.003_bib0195","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2215\/CJN.05000516","article-title":"Minimal change disease","volume":"12","author":"Vivarelli","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2023.04.003_bib0200","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00467-015-3082-x","article-title":"The glomerular permeability factors in idiopathic nephrotic syndrome","volume":"31","author":"Davin","year":"2016","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.nefroe.2023.04.003_bib0205","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1007\/s00467-005-1936-3","article-title":"Altered activity of plasma hemopexin in patients with minimal change disease in relapse","volume":"20","author":"Bakker","year":"2005","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.nefroe.2023.04.003_bib0210","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jaut.2017.12.014","article-title":"Autoantibodies against podocytic UCHL1 are associated with idiopathic nephrotic syndrome relapses and induce proteinuria in mice","volume":"89","author":"Jamin","year":"2018","journal-title":"J Autoimmun"},{"key":"10.1016\/j.nefroe.2023.04.003_bib0215","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1681\/ASN.2021060794","article-title":"Discovery of autoantibodies targeting nephrin in minimal change disease supports a novel autoimmune etiology","volume":"33","author":"Watts","year":"2022","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2023.04.003_bib0220","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41572-020-0196-7","article-title":"Podocytopathies","volume":"6","author":"Kopp","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.nefroe.2023.04.003_bib0225","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1046\/j.1523-1755.2001.00472.x","article-title":"Synaptopodin expression in idiopathic nephrotic syndrome of childhood","volume":"59","author":"Srivastava","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefroe.2023.04.003_bib0230","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/ndt\/18.1.70","article-title":"Altered ultrastructural distribution of nephrin in minimal change nephrotic syndrome","volume":"18","author":"Wernerson","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefroe.2023.04.003_bib0235","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1172\/JCI60070","article-title":"Crk1\/2-dependent signaling is necessary for podocyte foot process spreading in mouse models of glomerular disease","volume":"122","author":"George","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nefroe.2023.04.003_bib0240","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/ki.2008.19","article-title":"Decreased tyrosine phosphorylation of nephrin in rat and human nephrosis","volume":"73","author":"Uchida","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefroe.2023.04.003_bib0245","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1681\/ASN.2009090991","article-title":"Inhibition of podocyte FAK protects against proteinuria and foot process effacement","volume":"21","author":"Ma","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2023.04.003_bib0250","doi-asserted-by":"crossref","first-page":"e99083","DOI":"10.1371\/journal.pone.0099083","article-title":"Laminin \u03b12-mediated focal adhesion kinase activation triggers Alport glomerular pathogenesis","volume":"9","author":"Delimont","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.nefroe.2023.04.003_bib0255","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.1242\/jcs.02565","article-title":"Regulation of focal adhesion dynamics and disassembly by phosphorylation of FAK at tyrosine 397","volume":"118","author":"Hamadi","year":"2005","journal-title":"J Cell Sci"},{"key":"10.1016\/j.nefroe.2023.04.003_bib0260","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1681\/ASN.2018040362","article-title":"Nephrin signaling results in integrin \u03b21 activation","volume":"30","author":"Dlugos","year":"2019","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2023.04.003_bib0265","doi-asserted-by":"crossref","first-page":"E6467","DOI":"10.1073\/pnas.1722317115","article-title":"Targeting \u03b21-integrin inhibits vascular leakage in endotoxemia","volume":"115","author":"Hakanpaa","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.nefroe.2023.04.003_bib0270","doi-asserted-by":"crossref","first-page":"20365","DOI":"10.1074\/jbc.271.34.20365","article-title":"The inhibitory anti-beta1 integrin monoclonal antibody 13 recognizes an epitope that is attenuated by ligand occupancy. Evidence for allosteric inhibition of integrin function","volume":"271","author":"Mould","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nefroe.2023.04.003_bib0275","doi-asserted-by":"crossref","unstructured":"KDIGO 2021 clinical practice guideline for the management of glomerular diseases. Kidney Int. 2021;100:S1\u2013276, https:\/\/doi.org\/10.1016\/j.kint.2021.05.021.","DOI":"10.1016\/j.kint.2021.05.021"},{"key":"10.1016\/j.nefroe.2023.04.003_bib0280","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0022-3476(81)80760-3","article-title":"The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children","volume":"98","year":"1981","journal-title":"J Pediatr"},{"key":"10.1016\/j.nefroe.2023.04.003_bib0285","article-title":"Molecular mechanisms of proteinuria in minimal change disease","volume":"761600","author":"Purohit","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.nefroe.2023.04.003_bib0290","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S0022-3476(86)80876-9","article-title":"Role of respiratory viruses in exacerbations of primary nephrotic syndrome","volume":"108","author":"MacDonald","year":"1986","journal-title":"J Pediatr"},{"key":"10.1016\/j.nefroe.2023.04.003_bib0295","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1046\/j.1523-1755.2001.060003957.x","article-title":"Podocyte depletion and glomerulosclerosis have a direct relationship in the PAN-treated rat","volume":"60","author":"Kim","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefroe.2023.04.003_bib0300","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1007\/s00467-013-2498-4","article-title":"Serum from minimal change patients in relapse increases CD80 expression in cultured podocytes","volume":"28","author":"Ishimoto","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.nefroe.2023.04.003_bib0305","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.kint.2017.03.010","article-title":"Rac1 activation in podocytes induces the spectrum\u00a0of nephrotic syndrome","volume":"92","author":"Robins","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefroe.2023.04.003_bib0310","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1681\/ASN.2014090859","article-title":"A podocyte-based automated screening assay identifies protective small molecules","volume":"26","author":"Lee","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2023.04.003_bib0315","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1681\/ASN.2011040367","article-title":"Inhibition of integrin \u03b12\u03b21 ameliorates glomerular injury","volume":"23","author":"Borza","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2023.04.003_bib0320","doi-asserted-by":"crossref","first-page":"9265074","DOI":"10.1155\/2016\/9265074","article-title":"Upregulation of \u03b13\u03b21-integrin in podocytes in early-stage diabetic nephropathy","volume":"2016","author":"Sawada","year":"2016","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.nefroe.2023.04.003_bib0325","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1172\/JCI67846","article-title":"Podocyte-specific RAP1GAP expression contributes to focal segmental glomerulosclerosis-associated glomerular injury","volume":"124","author":"Potla","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nefroe.2023.04.003_bib0330","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00467-017-3677-5","article-title":"Immunology of idiopathic nephrotic syndrome","volume":"33","author":"Colucci","year":"2018","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.nefroe.2023.04.003_bib0335","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1210\/er.2009-0030","article-title":"Gut microbiota, lipopolysaccharides, and innate immunity in the pathogenesis of obesity and cardiovascular risk","volume":"31","author":"Manco","year":"2010","journal-title":"Endocr Rev"},{"key":"10.1016\/j.nefroe.2023.04.003_bib0340","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.2337\/dc09-0467","article-title":"Serum lipopolysaccharide activity is associated with the progression of kidney disease in Finnish patients with type 1 diabetes","volume":"32","author":"Nymark","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.nefroe.2023.04.003_bib0345","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-4528","article-title":"The effect of a gluten-free diet in children with difficult-to-manage nephrotic syndrome","volume":"138","author":"Lemley","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.nefroe.2023.04.003_bib0350","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1136\/adc.56.7.517","article-title":"Steroid-responsive nephrotic syndrome and allergy: immunological studies","volume":"56","author":"Meadow","year":"1981","journal-title":"Arch Dis Childhood"},{"key":"10.1016\/j.nefroe.2023.04.003_bib0355","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1681\/ASN.2007040395","article-title":"TLR4 links podocytes with the innate immune system to mediate glomerular injury","volume":"19","author":"Banas","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2023.04.003_bib0360","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/nm.4362","article-title":"A tripartite complex of suPAR APOL1 risk variants and \u03b1(v)\u03b2(3) integrin on podocytes mediates chronic kidney disease","volume":"23","author":"Hayek","year":"2017","journal-title":"Nat Med"},{"key":"10.1016\/j.nefroe.2023.04.003_bib0365","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.81836","article-title":"B cell-derived IL-4 acts on podocytes to induce proteinuria and foot process effacement","volume":"2","author":"Kim","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.nefroe.2023.04.003_bib0370","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.152102","article-title":"Steroid-sensitive nephrotic syndrome candidate gene CLVS1 regulates podocyte oxidative stress and endocytosis","volume":"7","author":"Lane","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.nefroe.2023.04.003_bib0375","doi-asserted-by":"crossref","first-page":"807","DOI":"10.4049\/jimmunol.141.3.807","article-title":"Massive proteinuria induced in rats by a single intravenous injection of a monoclonal antibody","volume":"141","author":"Orikasa","year":"1988","journal-title":"J Immunol"},{"key":"10.1016\/j.nefroe.2023.04.003_bib0380","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1681\/ASN.2015091048","article-title":"Nephrin tyrosine phosphorylation is required to stabilize and restore podocyte foot process architecture","volume":"27","author":"New","year":"2016","journal-title":"J Am Soc Nephrol"}],"container-title":["Nefrolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S201325142300072X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S201325142300072X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T19:51:43Z","timestamp":1761853903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S201325142300072X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S201325142300072X"],"URL":"https:\/\/doi.org\/10.1016\/j.nefroe.2023.04.003","relation":{},"ISSN":["2013-2514"],"issn-type":[{"type":"print","value":"2013-2514"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u03b21-Integrin blockade prevents podocyte injury in experimental models of minimal change disease","name":"articletitle","label":"Article Title"},{"value":"Nefrolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nefroe.2023.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Sociedad Espa\u00f1ola de Nefrolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}